Tenet Healthcare (THC) reported Q1 earnings of $3.22/share, up from $1.42, and received increased price targets and 'buy' ratings from financial institutions.
Tenet Healthcare (NYSE: THC) has received increased price targets and ratings from various financial institutions, with Royal Bank of Canada raising its target from $109 to $136 and UBS Group increasing theirs to $150. The consensus rating for THC is 'buy', with an average target price of $113.19. Q1 earnings reported $3.22 per share, up from $1.42 the previous year, beating analysts' estimates.
May 05, 2024
3 Articles